PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers

被引：2
|
作者：
Stebbing, Justin [1 ]
Ellis, Paul [2 ,3 ]
Tutt, Andrew [4 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Oncol & Surg, London W12 0NN, England
[2] Guys & St Thomas NHS Trust, Dept Oncol, London, England
[3] Kings Coll Hosp, London, England
[4] Guys Hosp, Breakthrough Breast Canc Res Unit, Kings Hlth Partners AHSC, London SE1 9RT, England
来源：
FUTURE ONCOLOGY | 2010年 / 6卷 / 04期
关键词：
breast cancer; BRCA; PARP inhibitor; triple negative; POLY(ADP-RIBOSE) POLYMERASE; RESISTANCE; DNA; REPAIR; MUTATIONS; TUMORS; BRCA1;
D O I：
10.2217/FON.10.27
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：485 / 486
页数：2
相关论文
共 50 条
  • [41] NGS-Based Mutation Analysis of BRCA1-Associated Triple-Negative Breast Cancers
    Honisch, Ellen
    Froehlich, Rose
    Vesper, Anne-Sophie
    Beyer, Ines
    Fehm, Tanja
    Niederacher, Dieter
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 197 - 197
  • [42] 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
    Peter Bouwman
    Amal Aly
    Jose M Escandell
    Mark Pieterse
    Jirina Bartkova
    Hanneke van der Gulden
    Sanne Hiddingh
    Maria Thanasoula
    Atul Kulkarni
    Qifeng Yang
    Bruce G Haffty
    Johanna Tommiska
    Carl Blomqvist
    Ronny Drapkin
    David J Adams
    Heli Nevanlinna
    Jiri Bartek
    Madalena Tarsounas
    Shridar Ganesan
    Jos Jonkers
    Nature Structural & Molecular Biology, 2010, 17 : 688 - 695
  • [43] Clinical management of BRCA1-and BRCA2-associated breast cancer
    Karp, SE
    SEMINARS IN SURGICAL ONCOLOGY, 2000, 18 (04): : 296 - 304
  • [44] BRCA1- and BRCA2-associated breast cancer is more sensitive to standard chemotherapy for metastatic disease in comparison with sporadic breast cancer.
    Kriege, M.
    Seynaeve, C.
    Meyers-Heijboer, H.
    Collee, M.
    Menke-Pluymers, M. B. E.
    Bartels, C. C. M.
    van den Ouweland, A.
    van Geel, B.
    Hooning, M.
    Brekelmans, C. T. M.
    Klijn, J. G. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S96 - S97
  • [45] 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
    Bouwman, Peter
    Aly, Amal
    Escandell, Jose M.
    Pieterse, Mark
    Bartkova, Jirina
    van der Gulden, Hanneke
    Hiddingh, Sanne
    Thanasoula, Maria
    Kulkarni, Atul
    Yang, Qifeng
    Haffty, Bruce G.
    Tommiska, Johanna
    Blomqvist, Carl
    Drapkin, Ronny
    Adams, David J.
    Nevanlinna, Heli
    Bartek, Jiri
    Tarsounas, Madalena
    Ganesan, Shridar
    Jonkers, Jos
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2010, 17 (06) : 688 - U56
  • [46] Familial non-BRCA1/BRCA2-associated breast cancer
    Eccles, DM
    Pichert, G
    LANCET ONCOLOGY, 2005, 6 (09): : 705 - 711
  • [47] Majority of BRCA2-associated breast cancers are estrogen receptor positive (ER) and different from BRCA1-associated breast cancers.
    Aboud, F
    Schlanger, C
    Olopade, OI
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (05) : 267A - 267A
  • [48] DNA repair pathway in BRCAX and BRCA1/2-associated hereditary triple-negative breast cancers
    Domagala, P.
    Hybiak, J.
    Cybulski, C.
    VIRCHOWS ARCHIV, 2015, 467 : S64 - S64
  • [49] Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer
    Anita K. Mehta
    Emily M. Cheney
    Christina A. Hartl
    Constantia Pantelidou
    Madisson Oliwa
    Jessica A. Castrillon
    Jia-Ren Lin
    Katie E. Hurst
    Mateus de Oliveira Taveira
    Nathan T. Johnson
    William M. Oldham
    Marian Kalocsay
    Matthew J. Berberich
    Sarah A. Boswell
    Aditi Kothari
    Shawn Johnson
    Deborah A. Dillon
    Mikel Lipschitz
    Scott Rodig
    Sandro Santagata
    Judy E. Garber
    Nadine Tung
    José Yélamos
    Jessica E. Thaxton
    Elizabeth A. Mittendorf
    Peter K. Sorger
    Geoffrey I. Shapiro
    Jennifer L. Guerriero
    Nature Cancer, 2021, 2 : 66 - 82
  • [50] Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer
    Mehta, Anita K.
    Cheney, Emily M.
    Hartl, Christina A.
    Pantelidou, Constantia
    Oliwa, Madisson
    Castrillon, Jessica A.
    Lin, Jia-Ren
    Hurst, Katie E.
    de Oliveira Taveira, Mateus
    Johnson, Nathan T.
    Oldham, William M.
    Kalocsay, Marian
    Berberich, Matthew J.
    Boswell, Sarah A.
    Kothari, Aditi
    Johnson, Shawn
    Dillon, Deborah A.
    Lipschitz, Mikel
    Rodig, Scott
    Santagata, Sandro
    Garber, Judy E.
    Tung, Nadine
    Yelamos, Jose
    Thaxton, Jessica E.
    Mittendorf, Elizabeth A.
    Sorger, Peter K.
    Shapiro, Geoffrey I.
    Guerriero, Jennifer L.
    NATURE CANCER, 2021, 2 (01) : 66 - +
12345